Anti Glaucoma Drugs Classification and Pharmacology for GPAT and NEETPG
ANTI-GLAUCOMA DRUGS
Glaucoma is managed primarily by lowering intraocular pressure (IOP) by either reducing aqueous humor production or increasing its outflow.
🗂️ CLASSIFICATION OF ANTI-GLAUCOMA DRUGS
A. Drugs that Decrease Aqueous Humor Production
-
Beta Blockers
-
Examples: Timolol, Betaxolol, Levobunolol
-
Mechanism: Block β-receptors in ciliary body → ↓ aqueous production
-
Notes: No effect on pupil size
-
-
Alpha-2 Adrenergic Agonists
-
Examples: Brimonidine, Apraclonidine
-
Mechanism: ↓ aqueous production + ↑ uveoscleral outflow
-
Side Effect: Allergic conjunctivitis, dry mouth
-
-
Carbonic Anhydrase Inhibitors (CAIs)
-
Topical: Dorzolamide, Brinzolamide
-
Oral: Acetazolamide, Methazolamide
-
Mechanism: Inhibit carbonic anhydrase → ↓ aqueous humor secretion
-
Side Effects: Paresthesia, renal stones, metabolic acidosis (systemic)
-
B. Drugs that Increase Aqueous Humor Outflow
-
Prostaglandin Analogues (first-line)
-
Examples: Latanoprost, Travoprost, Bimatoprost
-
Mechanism: ↑ uveoscleral outflow
-
Side Effects: Iris pigmentation, eyelash growth
-
-
Cholinergic (Miotics)
-
Examples: Pilocarpine, Carbachol
-
Mechanism: Contract ciliary muscle → opens trabecular meshwork → ↑ outflow
-
Side Effects: Brow ache, myopia, miosis, retinal detachment risk
-
-
Rho kinase inhibitors
-
Examples: Netarsudil
-
Mechanism: ↑ trabecular outflow + ↓ episcleral venous pressure
-
Newer class
- Important Books for GPAT
-
C. Combination Therapies
-
Timolol + Dorzolamide
-
Timolol + Brimonidine
-
Latanoprost + Timolol
🔬 MECHANISM SUMMARY TABLE
| Drug Class | ↓ Production | ↑ Outflow | Site |
|---|---|---|---|
| Beta blockers | ✅ | ❌ | Ciliary epithelium |
| Alpha-2 agonists | ✅ | ✅ | Ciliary + uveoscleral |
| Carbonic Anhydrase Inh. | ✅ | ❌ | Ciliary epithelium |
| Prostaglandin analogs | ❌ | ✅ | Uveoscleral pathway |
| Cholinergic agonists | ❌ | ✅ | Trabecular meshwork |
| Rho kinase inhibitors | ❌ | ✅ | Trabecular meshwork |
https://gpatindia.com/gpat-mock-test/Participate in GPAT MOCK Test
📝 Important MCQ Points
-
First-line drug in open-angle glaucoma → Latanoprost (PG analog)
-
Systemic CAI used in acute angle-closure glaucoma → Acetazolamide
-
Beta-blocker safe in asthma patients → Betaxolol (β1-selective)
-
Side effect of PG analogs → Iris pigmentation, eyelash thickening
-
Drug contraindicated in sulfonamide allergy → Acetazolamide